| Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures LM Hess, MA Raebel, DA Conner, DC Malone Annals of pharmacotherapy 40 (7-8), 1280-1288, 2006 | 894 | 2006 |
| A national estimate of the economic costs of asthma DH Smith, DC Malone, KA Lawson, LJ Okamoto, C Battista, WB Saunders American journal of respiratory and critical care medicine 156 (3), 787-793, 1997 | 798 | 1997 |
| Excessive antibiotic use for acute respiratory infections in the United States R Gonzales, DC Malone, JH Maselli, MA Sande Clinical infectious diseases 33 (6), 757-762, 2001 | 723 | 2001 |
| A cost of illness study of allergic rhinitis inthe United States DC Malone, KA Lawson, DH Smith, HM Arrighi, C Battista Journal of Allergy and Clinical Immunology 99 (1), 22-27, 1997 | 406 | 1997 |
| Health services use and health care costs of obese and nonobese individuals MA Raebel, DC Malone, DA Conner, S Xu, JA Porter, FA Lanty Archives of internal medicine 164 (19), 2135-2140, 2004 | 331 | 2004 |
| Cost-effectiveness of apixaban, dabigatran, rivaroxaban, and warfarin for stroke prevention in atrial fibrillation AR Harrington, EP Armstrong, PE Nolan Jr, DC Malone Stroke 44 (6), 1676-1681, 2013 | 312 | 2013 |
| Identification of serious drug-drug interactions: results of the partnership to prevent drug-drug interactions DC Malone, J Abarca, PD Hansten, AJ Grizzle, EP Armstrong, ... The American Journal of Geriatric Pharmacotherapy 3 (2), 65-76, 2005 | 282 | 2005 |
| Health care utilization and costs by metabolic syndrome risk factors DM Boudreau, DC Malone, MA Raebel, PA Fishman, GA Nichols, ... Metabolic syndrome and related disorders 7 (4), 305-314, 2009 | 255 | 2009 |
| International standards for the analysis of quality-of-life and patient-reported outcome endpoints in cancer randomised controlled trials: recommendations of the SISAQOL Consortium C Coens, M Pe, AC Dueck, J Sloan, E Basch, M Calvert, A Campbell, ... The Lancet Oncology 21 (2), e83-e96, 2020 | 242 | 2020 |
| Concordance of severity ratings provided in four drug interaction compendia J Abarca, DC Malone, EP Armstrong, AJ Grizzle, PD Hansten, ... Journal of the American Pharmacists Association 44 (2), 136-141, 2004 | 240 | 2004 |
| Social media mining for toxicovigilance: automatic monitoring of prescription medication abuse from Twitter A Sarker, K O’connor, R Ginn, M Scotch, K Smith, D Malone, G Gonzalez Drug safety 39, 231-240, 2016 | 235 | 2016 |
| Recommendations to improve the usability of drug-drug interaction clinical decision support alerts TH Payne, LE Hines, RC Chan, S Hartman, J Kapusnik-Uner, AL Russ, ... Journal of the American Medical Informatics Association 22 (6), 1243-1250, 2015 | 212 | 2015 |
| Analysing data from patient-reported outcome and quality of life endpoints for cancer clinical trials: a start in setting international standards A Bottomley, M Pe, J Sloan, E Basch, F Bonnetain, M Calvert, A Campbell, ... The Lancet Oncology 17 (11), e510-e514, 2016 | 204 | 2016 |
| Evaluation of machine-learning algorithms for predicting opioid overdose risk among medicare beneficiaries with opioid prescriptions WH Lo-Ciganic, JL Huang, HH Zhang, JC Weiss, Y Wu, CK Kwoh, ... JAMA network open 2 (3), e190968-e190968, 2019 | 203 | 2019 |
| The relationship between drug therapy noncompliance and patient characteristics, health‐related quality of life, and health care costs SJ Billups, DC Malone, BL Carter Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20 (8 …, 2000 | 193 | 2000 |
| Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study SL Ellis, BL Carter, DC Malone, SJ Billups, GJ Okano, RJ Valuck, ... Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 20 (12 …, 2000 | 188 | 2000 |
| Costs of {beta}-Lactam Allergies: Selection and Costs of Antibiotics for Patients With a Reported {beta}-Lactam Allergy EJ MacLaughlin, JJ Saseen, DC Malone Archives of family medicine 9 (8), 722, 2000 | 183 | 2000 |
| Challenges in the development and reimbursement of personalized medicine—payer and manufacturer perspectives and implications for health economics and outcomes research: a … E Faulkner, L Annemans, L Garrison, M Helfand, AP Holtorf, J Hornberger, ... Value in Health 15 (8), 1162-1171, 2012 | 161 | 2012 |
| Ability of pharmacy clinical decision-support software to alert users about clinically important drug—drug interactions KR Saverno, LE Hines, TL Warholak, AJ Grizzle, L Babits, C Clark, ... Journal of the American Medical Informatics Association 18 (1), 32-37, 2011 | 151 | 2011 |
| Prescribers’ knowledge of and sources of information for potential drug-drug interactions: a postal survey of US prescribers Y Ko, DC Malone, GH Skrepnek, EP Armstrong, JE Murphy, J Abarca, ... Drug Safety 31, 525-536, 2008 | 149 | 2008 |
